$10.21
+0.00 (+0.00%)
Open$10.21
Previous Close$10.21
Day High$10.21
Day Low$10.19
52W High$11.32
52W Low$10.11
Volume—
Avg Volume86.3K
Market Cap383.07M
P/E Ratio—
EPS$-0.03
SectorN/A
Analyst Ratings
Sell
9 analysts
Price Target
+225.7% upside
Current
$10.21
$10.21
Target
$33.25
$33.25
$21.69
$33.25 avg
$38.82
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 229.75M | 221.12M | 203.42M |
| Net Income | 18.67M | 19.49M | 13.94M |
| Profit Margin | 8.1% | 8.8% | 6.9% |
| EBITDA | 31.30M | 28.96M | 26.35M |
| Free Cash Flow | 15.11M | 9.40M | 12.42M |
| Rev Growth | +0.0% | -7.2% | +5.6% |
| Debt/Equity | 0.24 | 0.28 | 0.30 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.13 | +4.25% | — | 3.64B |
| PICS | Pics Nv | $15.73 | +4.73% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.99 | -0.20% | — | 655.09M |
| CCCX | Churchill Capital Corp X-A | $11.66 | +8.57% | — | 606.90M |
| BEAG | Bold Eagle Acquisition Cor-A | $10.53 | +0.10% | 63.0 | 605.14M |
| CEPF | Cantor Equity Partners-Cl A | $10.46 | +0.48% | 364.8 | 597.79M |